Studies have shown that CHMP4B (Charged multivesicular body protein 4B) is significantly overexpressed in HCC, which is associated with poor prognosis and drug resistance to doxorubicin (Hu et al., 2015). Here, CHMP4B is linked to hepatocellular carcinoma.